Legal & General Group PLC Genprex, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.11 - $4.87 $10,337 - $16,187	-3,324 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.66 - $7.67 $944 - $1,978	-258 Reduced 7.2%	3,324 $14,000
Q3 2020 Nov 13, 2020	SELL	$2.9 - $4.29 $3,253 - $4,813	-1,122 Reduced 23.85%	3,582 $12,000
Q2 2020 Aug 14, 2020	BUY	$1.99 - $3.64 $9,360 - $17,122	4,704 New	4,704 $15,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.